RSV Vaccines Market Size, Share & Industry Analysis, By Product (Abrysvo, Arexvy, mRESVIA, and Others), By Type (Inactivated, Recombinant/Conjugate/Subunit, mRNA Vaccine, and Others), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI110506

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Epidemiology of Respiratory Syncytial Virus (RSV)
2. Regulatory Framework, By Key Countries/Regions
3. Reimbursement Scenario, By Key Countries/Regions
4. New Product Launches & Approvals, By Key Players
5. Key Industry Developments (Merger, Acquisition, Collaboration, etc.)
6. Pipeline Analysis, By Key Players
Global RSV Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Abrysvo
  2. Arexvy
  3. mRESVIA
  4. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Inactivated
  2. Recombinant/Conjugate/Subunit
  3. mRNA Vaccine
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America RSV Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Abrysvo
  2. Arexvy
  3. mRESVIA
  4. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Inactivated
  2. Recombinant/Conjugate/Subunit
  3. mRNA Vaccine
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe RSV Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Abrysvo
  2. Arexvy
  3. mRESVIA
  4. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Inactivated
  2. Recombinant/Conjugate/Subunit
  3. mRNA Vaccine
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By County/ Sub-region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific RSV Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Abrysvo
  2. Arexvy
  3. mRESVIA
  4. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Inactivated
  2. Recombinant/Conjugate/Subunit
  3. mRNA Vaccine
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America RSV Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Abrysvo
  2. Arexvy
  3. mRESVIA
  4. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Inactivated
  2. Recombinant/Conjugate/Subunit
  3. mRNA Vaccine
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa RSV Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Abrysvo
  2. Arexvy
  3. mRESVIA
  4. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Inactivated
  2. Recombinant/Conjugate/Subunit
  3. mRNA Vaccine
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. South Africa
  2. GCC
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. GSK plc
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, Etc.
  2. Pfizer Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, Etc.
  3. Sanofi
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, Etc.
  4. Moderna Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, Etc.
  5. Blue Lake Biotechnology
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, Etc.
  6. Codagenix
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, Etc.
  7. AstraZeneca
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, Etc.
  8. Virometix
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, Etc.

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Epidemiology of Respiratory Syncytial Virus (RSV)
2. Regulatory Framework, By Key Countries/Regions
3. Reimbursement Scenario, By Key Countries/Regions
4. New Product Launches & Approvals, By Key Players
5. Key Industry Developments (Merger, Acquisition, Collaboration, etc.)
6. Pipeline Analysis, By Key Players
Global RSV Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Abrysvo
  2. Arexvy
  3. mRESVIA
  4. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Inactivated
  2. Recombinant/Conjugate/Subunit
  3. mRNA Vaccine
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America RSV Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Abrysvo
  2. Arexvy
  3. mRESVIA
  4. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Inactivated
  2. Recombinant/Conjugate/Subunit
  3. mRNA Vaccine
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe RSV Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Abrysvo
  2. Arexvy
  3. mRESVIA
  4. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Inactivated
  2. Recombinant/Conjugate/Subunit
  3. mRNA Vaccine
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By County/ Sub-region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific RSV Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Abrysvo
  2. Arexvy
  3. mRESVIA
  4. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Inactivated
  2. Recombinant/Conjugate/Subunit
  3. mRNA Vaccine
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America RSV Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Abrysvo
  2. Arexvy
  3. mRESVIA
  4. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Inactivated
  2. Recombinant/Conjugate/Subunit
  3. mRNA Vaccine
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa RSV Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Abrysvo
  2. Arexvy
  3. mRESVIA
  4. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Inactivated
  2. Recombinant/Conjugate/Subunit
  3. mRNA Vaccine
  4. Others
3. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. South Africa
  2. GCC
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. GSK plc
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, Etc.
  2. Pfizer Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, Etc.
  3. Sanofi
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, Etc.
  4. Moderna Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, Etc.
  5. Blue Lake Biotechnology
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, Etc.
  6. Codagenix
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, Etc.
  7. AstraZeneca
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, Etc.
  8. Virometix
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT, Etc.

Read Less

List of Figures

Figure 1: Global RSV Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2: Global RSV Vaccines Market Value Share (%), By Product, 2024 & 2032

Figure 3: Global RSV Vaccines Market Value Share (%), By Type, 2024 & 2032

Figure 4: Global RSV Vaccines Market Value Share (%), By Age Group, 2024 & 2032

Figure 5: Global RSV Vaccines Market Value Share (%), By Distribution Channel, 2024 & 2032

Figure 6: Global RSV Vaccines Market Value (USD billion), by Region, 2024 & 2032

Figure 7: North America RSV Vaccines Market Value (USD billion), By Product, 2024 & 2032

Figure 8: North America RSV Vaccines Market Value Share (%), By Product, 2024

Figure 9: North America RSV Vaccines Market Value (USD billion), By Type, 2024 & 2032

Figure 10: North America RSV Vaccines Market Value Share (%), By Type, 2024

Figure 11: North America RSV Vaccines Market Value (USD billion), By Age Group, 2024 & 2032

Figure 12: North America RSV Vaccines Market Value Share (%), By Age Group, 2024

Figure 13: North America RSV Vaccines Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 14: North America RSV Vaccines Market Value Share (%), By Distribution Channel, 2024

Figure 15: North America RSV Vaccines Market Value (USD billion), By Country, 2024 & 2032

Figure 16: North America RSV Vaccines Market Value Share (%), By Country, 2024

Figure 17: Europe RSV Vaccines Market Value (USD billion), By Product, 2024 & 2032

Figure 18: Europe RSV Vaccines Market Value Share (%), By Product, 2024

Figure 19: Europe RSV Vaccines Market Value (USD billion), By Type, 2024 & 2032

Figure 20: Europe RSV Vaccines Market Value Share (%), By Type, 2024

Figure 21: Europe RSV Vaccines Market Value (USD billion), By Age Group, 2024 & 2032

Figure 22: Europe RSV Vaccines Market Value Share (%), By Age Group, 2024

Figure 23: Europe RSV Vaccines Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 24: Europe RSV Vaccines Market Value Share (%), By Distribution Channel, 2024

Figure 25: Europe RSV Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 26: Europe RSV Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 27: Asia Pacific RSV Vaccines Market Value (USD billion), By Product, 2024 & 2032

Figure 28: Asia Pacific RSV Vaccines Market Value Share (%), By Product, 2024

Figure 29: Asia Pacific RSV Vaccines Market Value (USD billion), By Type, 2024 & 2032

Figure 30: Asia Pacific RSV Vaccines Market Value Share (%), By Type, 2024

Figure 31: Asia Pacific RSV Vaccines Market Value (USD billion), By Age Group, 2024 & 2032

Figure 32: Asia Pacific RSV Vaccines Market Value Share (%), By Age Group, 2024

Figure 33: Asia Pacific RSV Vaccines Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 34: Asia Pacific RSV Vaccines Market Value Share (%), By Distribution Channel, 2024

Figure 35: Asia Pacific RSV Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 36: Asia Pacific RSV Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 37: Latin America RSV Vaccines Market Value (USD billion), By Product, 2024 & 2032

Figure 38: Latin America RSV Vaccines Market Value Share (%), By Product, 2024

Figure 39: Latin America RSV Vaccines Market Value (USD billion), By Type, 2024 & 2032

Figure 40: Latin America RSV Vaccines Market Value Share (%), By Type, 2024

Figure 41: Latin America RSV Vaccines Market Value (USD billion), By Age Group, 2024 & 2032

Figure 42: Latin America RSV Vaccines Market Value Share (%), By Age Group, 2024

Figure 43: Latin America RSV Vaccines Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 44: Latin America RSV Vaccines Market Value Share (%), By Distribution Channel, 2024

Figure 45: Latin America RSV Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 46: Latin America RSV Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 47: Middle East & Africa RSV Vaccines Market Value (USD billion), By Product, 2024 & 2032

Figure 48: Middle East & Africa RSV Vaccines Market Value Share (%), By Product, 2024

Figure 49: Middle East & Africa RSV Vaccines Market Value (USD billion), By Type, 2024 & 2032

Figure 50: Middle East & Africa RSV Vaccines Market Value Share (%), By Type, 2024

Figure 51: Middle East & Africa RSV Vaccines Market Value (USD billion), By Age Group, 2024 & 2032

Figure 52: Middle East & Africa RSV Vaccines Market Value Share (%), By Age Group, 2024

Figure 53: Middle East & Africa RSV Vaccines Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 54: Middle East & Africa RSV Vaccines Market Value Share (%), By Distribution Channel, 2024

Figure 55: Middle East & Africa RSV Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 56: Middle East & Africa RSV Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 57: Global RSV Vaccines Market Share (%), By Company, 2024

List of Tables

Table 1: Global RSV Vaccines Market Revenue (USD billion) Forecast, By Product, 2019–2032

Table 2: Global RSV Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 3: Global RSV Vaccines Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 4: Global RSV Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 5: Global RSV Vaccines Market Revenue (USD billion) Forecast, by Region, 2019–2032

Table 6: North America RSV Vaccines Market Revenue (USD billion) Forecast, By Product, 2019–2032

Table 7: North America RSV Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 8: North America RSV Vaccines Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 9: North America RSV Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 10: North America RSV Vaccines Market Revenue (USD billion) Forecast, By Country, 2019–2032

Table 11: Europe RSV Vaccines Market Revenue (USD billion) Forecast, By Product, 2019–2032

Table 12: Europe RSV Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 13: Europe RSV Vaccines Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 14: Europe RSV Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 15: Europe RSV Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019–2032

Table 16: Asia Pacific RSV Vaccines Market Revenue (USD billion) Forecast, By Product, 2019–2032

Table 17: Asia Pacific RSV Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 18: Asia Pacific RSV Vaccines Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 19: Asia Pacific RSV Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 20: Asia Pacific RSV Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019–2032

Table 21: Latin America RSV Vaccines Market Revenue (USD billion) Forecast, By Product, 2019–2032

Table 22: Latin America RSV Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 23: Latin America RSV Vaccines Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 24: Latin America RSV Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 25: Latin America RSV Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019–2032

Table 26: Middle East & Africa RSV Vaccines Market Revenue (USD billion) Forecast, By Product, 2019–2032

Table 27: Middle East & Africa RSV Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 28: Middle East & Africa RSV Vaccines Market Revenue (USD billion) Forecast, By Age Group, 2019–2032

Table 29: Middle East & Africa RSV Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 30: Middle East & Africa RSV Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019–2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 219

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com